LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

Search

McKesson Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

942.1 -0.11

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

921

Max

947.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

40M

1.3B

Pardavimai

3B

106B

P/E

Sektoriaus vid.

27.246

57.833

Dividendų pajamingumas

0.33

Pelno marža

1.177

Darbuotojai

43,000

EBITDA

374M

1.8B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+5.71% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.33%

2.47%

Kitas uždarbis

2026-05-07

Kitas dividendų mokėjimo data

2026-04-01

Kita Ex Dividend data

2026-06-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

11B

116B

Ankstesnė atidarymo kaina

942.21

Ankstesnė uždarymo kaina

942.1

Naujienos nuotaikos

By Acuity

44%

56%

134 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

McKesson Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-17 22:42; UTC

Uždarbis

Prudential PLC 2025 Adjusted Operating Profit Rises

2026-03-17 21:40; UTC

Uždarbis

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

2026-03-17 23:56; UTC

Rinkos pokalbiai

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

2026-03-17 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-17 23:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-17 23:42; UTC

Rinkos pokalbiai

RBA's Return to Policy Tightening Will Work -- Market Talk

2026-03-17 23:38; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

2026-03-17 23:24; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-03-17 23:24; UTC

Rinkos pokalbiai

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

2026-03-17 22:22; UTC

Rinkos pokalbiai

BHP Hands Reins to Growth-Focused Executive -- Market Talk

2026-03-17 22:20; UTC

Uždarbis

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

2026-03-17 22:20; UTC

Uždarbis

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

2026-03-17 22:07; UTC

Uždarbis

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

2026-03-17 22:05; UTC

Uždarbis

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

2026-03-17 22:04; UTC

Uždarbis

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

2026-03-17 22:03; UTC

Uždarbis

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

2026-03-17 22:01; UTC

Uždarbis

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

2026-03-17 22:01; UTC

Uždarbis

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

2026-03-17 22:01; UTC

Uždarbis

ZTO Express (Cayman) 4Q EPS 47c >ZTO

2026-03-17 21:26; UTC

Uždarbis

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

2026-03-17 21:09; UTC

Uždarbis

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

2026-03-17 21:08; UTC

Uždarbis

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

2026-03-17 21:08; UTC

Uždarbis

Couche-Tard 3Q Adj EPS 81c >ATD.T

2026-03-17 21:07; UTC

Uždarbis

Couche-Tard 3Q EPS 82c >ATD.T

2026-03-17 21:06; UTC

Uždarbis

Couche-Tard 3Q Rev $21.8B >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q Adj EPS 81c >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q Rev $21.8B >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q EPS 82c >ATD.T

2026-03-17 21:05; UTC

Uždarbis

Couche-Tard 3Q Net $757.2M >ATD.T

2026-03-17 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

McKesson Corp Prognozė

Kainos tikslas

By TipRanks

5.71% į viršų

12 mėnesių prognozė

Vidutinis 997.1 USD  5.71%

Aukščiausias 1,107 USD

Žemiausias 885 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines McKesson Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

11 ratings

9

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

681.92 / 707.28Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

No Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

134 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat